From March 2nd to 4th, AB7 Santé participated in the 12th edition of the Animal Health & Nutrition Technology Innovation Europe(AHNTI EU), held at Convene Sancroft, London. This essential event annually brings together key players in the veterinary pharmaceutical industry to discuss new market expectations and foster the technologies and collaborations of tomorrow.

As a CDMO/CMO committed to developing innovative solutions, AB7 Santé could not miss this major industry event. The event was an opportunity to highlight the expertise of our teams, who are dedicated to supporting our partners in their projects and contributing to the success of their development goals.

Present at the event, Arnaud Vilbert, R&D and Business Development Director, met with numerous international stakeholders and discussed challenges related to animal health and welfare, industrial innovation, and new collaboration opportunities.

These discussions particularly highlighted our expertise in veterinary pharmaceutical development and manufacturing, our exclusive drug delivery systems, our Petcare range, and our distribution expertise. Several promising co-development avenues were explored, paving the way for future joint projects.

More information: https://www.ahnti-eu.com/events/ahnti-eu

‍